Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand

Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205

NCT02852005 ·Status: COMPLETED ·Phase: PHASE1

Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial

NCT00337181 ·Status: COMPLETED

Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B

NCT00007332 ·Status: COMPLETED ·Phase: PHASE2

Thai Prophylactic HIV Vaccine Phase I Study

NCT00333424 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected Adults

NCT02207920 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults

NCT00415649 ·Status: WITHDRAWN ·Phase: PHASE2

Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects

NCT01428596 ·Status: UNKNOWN ·Phase: PHASE1

Phase I Study of Vaccination Schedule of Experimental HIV Vaccines

NCT00321061 ·Status: COMPLETED ·Phase: PHASE1

Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E

NCT01931358 ·Status: UNKNOWN ·Phase: PHASE2

Open-label, Phase I/IIa Study of VAC-3S in HIV-1 Patients Who Showed an Immune Response to VAC-3S During IVVAC-3S/P1

NCT02390466 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers

NCT00083330 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults

NCT01964937 ·Status: WITHDRAWN ·Phase: PHASE1

Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults

NCT00270218 ·Status: COMPLETED ·Phase: PHASE1

Vaccine Treatment for HIV-Infection

NCT00108654 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults

NCT00124007 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and Immunogenicity of an Oral HIV Vaccine in Healthy, HIV-uninfected Adults

NCT02771730 ·Status: TERMINATED ·Phase: PHASE1

Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS

NCT00963235 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine

NCT01320176 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating Vaccine in Adults With HIV

NCT00195312 ·Status: TERMINATED ·Phase: PHASE1

Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients

NCT00219362 ·Status: COMPLETED ·Phase: PHASE2

RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV

NCT06484335 ·Status: RECRUITING ·Phase: PHASE1

Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials

NCT01376726 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating Vaccine in Adults With HIV

NCT00195234 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1)

NCT04554966 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine

NCT00001136 ·Status: COMPLETED ·Phase: PHASE1